SOX2 and neoplasm: In recent years, a growing body of investigations has consistently demonstrated that SOX2 plays a pivotal role in driving distant metastasis, tumour invasion, radioresistance, and drug resistance through the induction of epithelial-mesenchymal transition (EMT) in tumour epithelial cells [19].